News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
182,200 Results
Type
Article (17544)
Company Profile (120)
Press Release (164536)
Section
Business (58248)
Career Advice (941)
Deals (9365)
Drug Delivery (36)
Drug Development (23459)
Employer Resources (70)
FDA (2337)
Job Trends (4235)
News (92255)
Policy (5782)
Tag
Academia (482)
Alliances (16212)
Alzheimer's disease (417)
Antibody-drug conjugate (ADC) (70)
Approvals (2303)
Artificial intelligence (88)
Bankruptcy (81)
Best Places to Work (2896)
Biotechnology (111)
Breast cancer (76)
Cancer (698)
Career advice (756)
CAR-T (80)
Cell therapy (232)
Clinical research (18517)
Collaboration (363)
Compensation (80)
COVID-19 (743)
C-suite (108)
Data (587)
Diabetes (55)
Diagnostics (1067)
Drug discovery (54)
Earnings (15740)
Employer resources (68)
Events (31106)
Executive appointments (313)
FDA (2581)
Funding (307)
Gene therapy (156)
GLP-1 (255)
Government (618)
Healthcare (2383)
Immunology and inflammation (52)
Infectious disease (792)
Inflammatory bowel disease (63)
Interviews (137)
IPO (4109)
Job creations (1472)
Job search strategy (701)
Layoffs (158)
Legal (1184)
Lung cancer (82)
Lymphoma (50)
Manufacturing (124)
Medical device (679)
Medtech (680)
Mergers & acquisitions (5423)
Metabolic disorders (197)
Neuroscience (604)
NextGen: Class of 2025 (1445)
Non-profit (451)
Northern California (763)
Obesity (109)
Opinion (171)
Patents (60)
People (22029)
Phase I (7208)
Phase II (8848)
Phase III (4967)
Pipeline (324)
Postmarket research (306)
Preclinical (2916)
Press Release (61)
Radiopharmaceuticals (81)
Rare diseases (154)
Real estate (2434)
Regulatory (4452)
Research institute (514)
Resumes & cover letters (152)
Series A (74)
Southern California (715)
Startups (1779)
United States (6397)
Vaccines (206)
Weight loss (80)
Date
Today (4)
Last 7 days (218)
Last 30 days (997)
Last 365 days (12517)
2025 (1712)
2024 (12665)
2023 (13227)
2022 (16070)
2021 (16950)
2020 (13204)
2019 (9508)
2018 (7538)
2017 (8976)
2016 (8111)
2015 (9408)
2014 (9724)
2013 (9448)
2012 (6079)
2011 (6451)
2010 (5840)
Location
Africa (324)
Asia (13405)
Australia (2667)
California (1792)
Canada (627)
China (161)
Connecticut (74)
Europe (30108)
Florida (194)
Illinois (121)
Indiana (95)
Maryland (275)
Massachusetts (1417)
Michigan (70)
Minnesota (105)
New Jersey (478)
New York (464)
North Carolina (319)
Northern California (763)
Pennsylvania (383)
South America (400)
Southern California (715)
Texas (206)
Washington State (299)
182,200 Results for "hookipa biotech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
January 30, 2025
·
6 min read
Executive appointments
Women Leaders Decline in Biotech’s Era of ‘Proven Leadership’
Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a
BioSpace
analysis. This is happening in an era of biotech where new company founders are searching for CEOs with a track record.
February 5, 2025
·
8 min read
·
Annalee Armstrong
Pharm Country
HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting
HOOKIPA Pharma Inc. today announced that members of HOOKIPA’s Executive Team will host an investor call on June 4, 2024, at 4:15 p.m. ET.
May 30, 2024
·
5 min read
Pharm Country
HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration
HOOKIPA Pharma Inc. announced that members of HOOKIPA’s Executive Team will host an investor call summarizing the Company’s constructive regulatory interactions with the U.S. Food & Drug Administration and the European Medicines Agency.
April 10, 2024
·
5 min read
Legal
Novo Seeks $830M in Fraud Case Against Singaporean Biotech Over Kidney Drug
Back in 2023, Novo Nordisk committed up to $1.3 billion for a hypertension and kidney disease drug from KBP Biosciences. Now, the pharma giant claims to have been misled by the biotech’s founder—and a judge seems to agree.
February 18, 2025
·
1 min read
·
Annalee Armstrong
Pharm Country
HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference
HOOKIPA Pharma Inc. announced that HOOKIPA’s Chief Financial Officer, Reinhard Kandera, will present at the Leerink Partners Global Biopharma Conference on March 13, 2024.
March 6, 2024
·
3 min read
Press Releases
HOOKIPA Pharma’s Eseba-vec Highlighted in SITC Late-Breaker
November 12, 2024
·
6 min read
Cystic Fibrosis
Cystic Fibrosis Biotech Sionna Announces $150M IPO
The Massachusetts-based biotech plans to use the funds to push its candidates into mid-stage clinical trials in a space dominated by Vertex.
February 3, 2025
·
1 min read
·
Dan Samorodnitsky
Leadership
Biotech CEO Sisterhood Fills ‘Unmet Need’ for Fellowship Among Women Leaders
At the J.P. Morgan Healthcare Conference, the Biotech CEO Sisterhood assembled in Union Square to showcase the large group of women and allies in biopharma as their authentic selves.
February 5, 2025
·
4 min read
·
Annalee Armstrong
Business
HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
HOOKIPA Pharma Inc., a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, reported financial results and recent business highlights for the first quarter of 2024.
May 9, 2024
·
11 min read
1 of 18,220
Next
